Why the study?
Is the APOE promoter polymorphism (A -491T) associated with essential hypertension or blood pressure variation in a Japanese population?
Is the APOE promoter polymorphism (A -491T) associated with essential hypertension or blood pressure variation in a Japanese population?
The APOE promoter polymorphism (A -491T) is not a major risk factor for hypertension but may have a minor effect on basal diastolic blood pressure variation in normotensive Japanese individuals.
Answers are grounded in this paper and cite their sources.
APOE promoter variant was not linked to hypertension; leaves open minor role in diastolic BP variation among normotensives.
The epsilon4 allele of apolipoprotein E (APOE) is reported to be a genetic risk factor of atherosclerosis through hyperlipidemia and late-onset Alzheimer's dementia. A recent report showed that a genetic variant (A -491T) in the promoter region of the APOE gene increases the risk of Alzheimer's disease. In the present study, we examined whether these APOE polymorphisms were genetically involved in essential hypertension. Japanese hypertensives (n=180) with a family history of hypertension and normotensive controls (n=195, sex and age matched with hypertensives) were recruited from the outpatients of Osaka University Hospital, and an informed consent to participate in the study was obtained from each person. APOE polymorphisms were determined using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The frequencies of the A -491 allele in hypertensives and normotensives were 0.98 and 0.97, respectively, and the TT/-491 genotype was not found in either group. No significant differences between hypertensives and normotensives were observed in allele frequencies in either APOE polymorphism; however, the mean diastolic blood pressure in normotensive subjects with AA/-491 was significantly higher than in the subjects with AT/-491 (p < 0.01). These results suggest that the presence of the APOE promoter polymorphism is not a major risk factor for hypertension but that it does have some minor effect on basal blood pressure variation.
No takes yet. Share an insight, caveat, or question.
Katsuya et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: